The chemistry is right for SB

The UK's second biggest drug company looks attractive, with a healthy stream of new products

INVESTORS who are into drugs have had plenty of trips and some interesting highs for their money of late, as the pharmaceuticals sector outperforms the overall stock market.

Takeover rumours have sent Zeneca zooming, a bid on the table has injected new life into Fisons, and Glaxo Wellcome has seen its shares spark after encouraging reports on the effectiveness of its Aids drug AZT.

SmithKline Beecham has also joined in the party. Its "A" shares, which stood at 460p at the beginning of the year, have gained new momentum over the past few months.

Last week, they hit record highs ahead of the group's key briefing meetings with UK and US analysts, focusing on the group's all-important portfolio of drugs under development.

SB announced it would be seeking approval for around 50 products over the next three years. Among these are 13 new drugs, as well as a raft of variations on existing products.

The most significant of the new products include its Coreg/ Kredex drug for congestive heart failure, Hycamtin for ovarian cancer, Ropinirole for Parkinson's disease, and the asthma treatment Pranlukast.

A healthy flow of new drugs and potential blockbuster products is the life blood of all drug companies, not least SB, whose previous big earner, the ulcer drug Tagamet, came off patent last year. Analysts were impressed, and strong buying on both sides of the Atlantic pushed its "A" shares even higher.

In the UK, SB plays second fiddle to the new Glaxo Wellcome combine, and worldwide it is the sixth largest group. On top of that, last year's flurry of acquisitions helped propel it to number three in the fast-growing consumer healthcare market.

SB also hits the top of the league table for chief executive pay. Former boss Bob Bauman was one of the first to break the pounds lm-a-year barrier, and the current head, Danish-born former Wimbledon semi-finalist Jan Leschley, took home a handy pounds 2.4m package last year.

However, the pace of change since Mr Leschley took over has sidelined the debate over pay. SB's pounds 5bn acquisition bonanza last year added US drug distributor DPS, as well as Sterling Health, a leader in over-the- counter medicines. SB subsequently sold Sterling's US brands to Bayer of Germany, and also disposed of its own animal health arm as part of the group shake-up.

Pharmaceuticals make up around three-quarters of trading profits at SB, while 16 per cent come from its consumer health division, spanning brands such as Panadol, Night Nurse, Macleans toothpaste, Ribena, and Lucozade.

The acquisitions put what Mr Leschley described as the main components in place for future growth. While analysts admire the strategy, reinforcing SB's position in the consolidating international drugs market, some query whether pounds l.4bn was too generous a price for the drug distributor DPS.

The restructuring has left SB with hefty borrowings to finance - net debt is just over pounds 2bn, putting gearing at the half-year at around 100 per cent. A further pounds 580m has been earmarked for restructuring costs over the next three years.

After his racing start as head of SB, Mr Leschley is having to meet high expectations, as analysts look for strong earnings growth and the full benefits of the recent acquisitions to kick in.

SB at least has two significant advantages over rival Glaxo Wellcome. First, it is six years into its big merger, after its link-up with Beecham in 1989, while Glaxo is just beginning to get to grips with Wellcome.

Secondly, SB has already absorbed the impact of Tagamet losing its patent protection, whereas for Glaxo, the end of the line for its key product Zantac looms in 1997.

SB confounded gloomy predictions with its first-half figures in July. Impressive growth from new drugs such as the anti-depressant treatment Seroxat and an anti-nausea drug, Kyril, helped offset the sharp fall in Tagamet sales.

Trading remains tough for all the drugs companies. With the emphasis in the US and UK on cheaper health care, the name of the game, Mr Leschley says, is volume rather than margin growth, topped up by increased efficiency and cost-cutting to drive future earnings growth.

Despite the caution, analysts remain bullish on overall market prospects, a view that has underpinned the sector's growth this year.

Analysts are looking for profits at SB for the year to December to top pounds l.33bn against pounds l.27bn last time, with the group on a multiple around 18, which looks high but is not too demanding given market forecasts.

While the shares may see profit-taking in the short term, SB's promise of strong growth from a broad range of drugs in lucrative markets should ensure they retain their appeal.

SmithKline Beecham

Share price 640p Prospective yield 2.7% Prospective price-earnings ratio 18.7 Dividend cover 2.46 1993 1994 1995*

Sales pounds 6.16bn pounds 6.49bn pounds 6.94bn Pre-tax profits pounds 1.16bn pounds 1.27bn pounds 1.35bn Earnings per share 29.1p 32.3p 34.2p Dividend per share 10.9p 12.9p 13.9p

* Nikko Europe forecast

footballLIVE City face Stoke, while Warnock returns to Palace dugout
Life and Style
3D printed bump keys can access almost any lock
gadgets + echSoftware needs photo of lock and not much more
Arts and Entertainment
Inside the gallery at Frederick Bremer School in Walthamstow
tvSimon Usborne goes behind the scenes to watch the latest series
Life and Style
Silvia says of her famous creation: 'I never stopped wearing it. Because I like to wear things when they are off the radar'
fashionThe fashion house celebrated fifteen years of the punchy pouch with a weighty tome
Arts and Entertainment
Gregg Wallace in Summer's Supermarket Secrets
tv All of this year's 15 contestants have now been named
i100Steve Carell selling chicken, Tina Fey selling saving accounts and Steve Colbert selling, um...
Life and Style
A picture taken on January 12, 2011 shows sex shops at the Paris district of Pigalle.
newsThe industry's trade body issued the moratorium on Friday
Arts and Entertainment
Could we see Iain back in the Bake Off tent next week?
tv Contestant teased Newsnight viewers on potential reappearance
ebooksAn evocation of the conflict through the eyes of those who lived through it
The slice of Prince Charles and Princess Diana's wedding cake and the original box from 29 July 1981
newsPiece of Charles and Diana's wedding cake sold at auction in US
The Ukip leader has consistently refused to be drawn on where he would mount an attempt to secure a parliamentary seat
voicesNigel Farage: Those who predicted we would lose momentum heading into the 2015 election are going to have to think again
Arts and Entertainment
Cara Delevingne made her acting debut in Anna Karenina in 2012
film Cara Delevingne 'in talks' to star in Zoolander sequel
Mario Balotelli pictured in his Liverpool shirt for the first time
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Network Engineer (CCNP, CCNA, Linux, OSPF, BGP, Multicast, WAN)

£35000 per annum: Harrington Starr: Network Engineer (CCNP, CCNA, Linux, OSPF,...

DevOps Engineer (Systems Administration, Linux, Shell, Bash)

£50000 per annum: Harrington Starr: DevOps Engineer (Systems Administration, L...

Data Scientist (SQL, PHP, RSPSS, CPLEX, SARS, AI) - London

£60000 - £70000 per annum: Harrington Starr: A prestigious leading professiona...

Financial Technical Consultant (C++, C#, Finance, MSc, PhD)

£50000 per annum: Harrington Starr: Financial Technical Consultant (C++, C#, F...

Day In a Page

Ukraine crisis: The phoney war is over as Russian troops and armour pour across the border

The phoney war is over

Russian troops and armour pour into Ukraine
Potatoes could be off the menu as crop pests threaten UK

Potatoes could be off the menu as crop pests threaten UK

The world’s entire food system is under attack - and Britain is most at risk, according to a new study
Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Seoul's plastic surgery industry is booming thanks to the popularity of the K-Pop look
From Mozart to Orson Welles: Creative geniuses who peaked too soon

Creative geniuses who peaked too soon

After the death of Sandy Wilson, 90, who wrote his only hit musical in his twenties, John Walsh wonders what it's like to peak too soon and go on to live a life more ordinary
Caught in the crossfire of a cyber Cold War

Caught in the crossfire of a cyber Cold War

Fears are mounting that Vladimir Putin has instructed hackers to target banks like JP Morgan
Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years

Salomé: A head for seduction

Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years. Now audiences can meet the Biblical femme fatale in two new stage and screen projects
From Bram Stoker to Stanley Kubrick, the British Library's latest exhibition celebrates all things Gothic

British Library celebrates all things Gothic

Forthcoming exhibition Terror and Wonder: The Gothic Imagination will be the UK's largest ever celebration of Gothic literature
The Hard Rock Café's owners are embroiled in a bitter legal dispute - but is the restaurant chain worth fighting for?

Is the Hard Rock Café worth fighting for?

The restaurant chain's owners are currently embroiled in a bitter legal dispute
Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival

In search of Caribbean soul food

Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival
11 best face powders

11 best face powders

Sweep away shiny skin with our pick of the best pressed and loose powder bases
England vs Norway: Roy Hodgson's hands tied by exploding top flight

Roy Hodgson's hands tied by exploding top flight

Lack of Englishmen at leading Premier League clubs leaves manager hamstrung
Angel Di Maria and Cristiano Ronaldo: A tale of two Manchester United No 7s

Di Maria and Ronaldo: A tale of two Manchester United No 7s

They both inherited the iconic shirt at Old Trafford, but the £59.7m new boy is joining a club in a very different state
Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

Robert Fisk: No victory for Israel despite weeks of devastation

Palestinians have won: they are still in Gaza, and Hamas is still there
Mary Beard writes character reference for Twitter troll who called her a 'slut'

Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

The Cambridge University classicist even wrote the student a character reference
America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

America’s new apartheid

Prosperous white districts are choosing to break away from black cities and go it alone